BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

South Korea’s Galux Inc. Achieves Breakthrough in AI-Driven Antibody Design for Multiple Therapeutic Targets

Pioneering AI technology successfully designs antibodies de novo for six therapeutic targets, including one without an experimentally resolved structure ...

March 18, 2025 | News

C2N Diagnostics Secures $10M Investment from Samsung to Expand Alzheimer’s Blood Biomarker Testing

-C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, announced a $...

March 14, 2025 | News

GC Cell Begins Phase 1 Clinical Trial for CD5 CAR-NK Therapy GCC2005 in T-Cell Lymphomas

GC Cell , under the leadership of CEO Sungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for GCC2005 (AB‑205), a no...

March 13, 2025 | News

Celltrion Launches STEQEYMA®, a Biosimilar to STELARA®, in the U.S. at an 85% Lower WAC List Price

STEQEYMA®, one of the first-wave biosimilars to STELARA®, is now available in the U.S. Approved for the same indications as the reference produc...

March 13, 2025 | News

WuXi XDC and AbTis Partner to Advance Site-Selective ADC Conjugation

WuXi XDC Cayman Inc. ("WuXi XDC" or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organiza...

March 12, 2025 | News

South Korea’s Lunit AI Proven to Enhance Breast Cancer Detection in Landmark Multicenter Study

Lunit, a global leader in AI-powered cancer diagnostics, has announced groundbreaking results from the world’s first large-scale, multicenter, prospe...

March 11, 2025 | News

NEXTBIOMEDICAL’s Nexsphere-F™ Secures FDA Breakthrough Device Designation for Osteoarthritis Pain Treatment

NEXTBIOMEDICAL CO., LTD, a leading developer of cutting-edge Devices, announced that its groundbreaking product 'Nexsphere-F™,' a resorbable microsph...

March 07, 2025 | News

DeepQure Advances Novel Renal Denervation Technology with Clinical Success in U.S. and South Korea

DeepQure Inc, a pioneering medical device startup, is revolutionizing the treatment of resistant hypertension with its innovative extravascular (laparoscop...

March 04, 2025 | News

Sunflower Therapeutics and PharmNXT Biotech Partner to Launch Daisy Petal™ Perfusion Bioreactor in Asia

-Sunflower Therapeutics (Sunflower), a public benefit corporation transforming global access to protein manufacturing capacity for diverse application...

February 28, 2025 | News

SK Bioscience Advances mRNA Vaccine for Japanese Encephalitis with Phase 1/2 Trials in Australia and New Zealand

SK bioscience’s first mRNA vaccine candidate enters Phase 1/2 clinical trials in Australia and New Zealand, with interim results expected by 2026. ...

February 25, 2025 | News

PranaQ Secures FDA Clearance for TipTraQ, an AI-Powered Home Sleep Apnea Testv

PranaQ, backed by NAVER D2SF continues to push the boundaries of AI-powered healthcare solutions. NAVER D2SF, NAVER's corporate venturing arm, actively col...

February 21, 2025 | News

South Korea’s Brexogen Out-Licenses BxC-I17e to BMI Korea in Landmark Exosome Therapeutics Deal

Out-licenses BxC-I17e, Exosome-Based Therapeutics for New IndicationsKRW 3 Billion Non-Refundable Upfront Payment + Milestone Payments + Double-Digit ...

February 20, 2025 | News

South Korea’s Celltrion Secures EU Approval for Three Biosimilar Products, Expanding Its Portfolio to 11 by 2025

Celltrion gains simultaneous regulatory approval of two monoclonal antibody biosimilars across three treatments – Eydenzelt® (aflibe...

February 19, 2025 | News

VIVOZON’s UNAFRA Inj. Secures MFDS Approval as South Korea’s First First-in-Class Non-Opioid Analgesic

VIVOZON Pharmaceutical announced that its non-opioid analgesic, UNAFRA Inj., was approved on December 12, 2024. (active ingredient: Opiranserin H...

February 19, 2025 | News

Stay Connected